Furthermore, focusing on OSNA+ SLNs, we showed, for the first time, that the concomitance of a low CK19 mRNA copy number (<2000) and a luminal tumor phenotype may be a useful, objective tool for predicting non-SLN positivity. The gene discussed is KRT19; the disease is neoplasm.